US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

vancomycin added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-7060-1 D-0736-2023
Class II · Moderate risk Terminated

phenylephrine 50 mg added to 0.9% sodium chloride 250 mL*

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-7039-1 D-0735-2023
Class II · Moderate risk Terminated

NORepinephrine added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-7036-1 D-0734-2023
Class II · Moderate risk Terminated

PHENYLephrine added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-7025-1 D-0733-2023
Class II · Moderate risk Terminated

heparin added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-7023-1 D-0732-2023
Class II · Moderate risk Terminated

heparin added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-7022-1 D-0731-2023
Class II · Moderate risk Terminated

EPINEPHrine added to dextrose 5%

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-7019-1 D-0730-2023
Class II · Moderate risk Terminated

EPINEPHrine added to dextrose 5%

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-7018-1 D-0729-2023
Class II · Moderate risk Terminated

PHENYLephrine added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-7011-1 D-0727-2023
Class II · Moderate risk Terminated

heparin added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-7009-1 D-0726-2023
Class II · Moderate risk Terminated

vancomycin added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6176-1 D-0725-2023
Class II · Moderate risk Terminated

PHENYLephrine added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6092-1 D-0724-2023
Class II · Moderate risk Terminated

vancomycin added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6078-1 D-0723-2023
Class II · Moderate risk Terminated

vancomycin added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6076-1 D-0722-2023
Class II · Moderate risk Terminated

vancomycin added to dextrose 5%

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6075-1 D-0721-2023
Class II · Moderate risk Terminated

vancomycin added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6074-1 D-0720-2023
Class II · Moderate risk Terminated

vancomycin added to dextrose 5%

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6073-1 D-0719-2023
Class II · Moderate risk Terminated

vancomycin added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6071-1 D-0718-2023
Class II · Moderate risk Terminated

vancomycin added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6064-1 D-0717-2023
Class II · Moderate risk Terminated

PHENYLephrine added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6058-1 D-0715-2023
Class II · Moderate risk Terminated

norepinephrine 4 mg added to dextrose 5% 250 mL*

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6056-1 D-0714-2023
Class II · Moderate risk Terminated

dilTIAZem added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6055-1 D-0713-2023